David P Meeker's Net Worth
$15.3 Million
Who is David P Meeker?
David P Meeker has an estimated net worth of $15.3 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., GENZYME CORP, SAVIENT PHARMACEUTICALS INC, MyoKardia Inc, Trevi Therapeutics, Inc., TURMERIC ACQUISITION CORP., and PENWEST PHARMACEUTICALS CO.
SEC CIK
David P Meeker's CIK is 0001385155
Past Insider Trading and Trends
2020 was David P Meeker's most active year for acquiring shares with 8 total transactions. David P Meeker's most active month to acquire stocks was the month of May. 2011 was David P Meeker's most active year for disposing of shares, totalling 18 transactions. David P Meeker's most active month to dispose stocks was the month of March. 2010 saw David P Meeker paying a total of $3,547,132.72 for 96,929 shares, this is the most they've acquired in one year. In 2011 David P Meeker cashed out on 476,761 shares for a total of $24,809,604.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.67% | -45.49K |
$39.22 | -$1,784,274.68 | 174.6K |
Mar 19
| |||
Form 4
| +81.75% | 99K |
—
|
—
| 220.1K |
Feb 16
| |||
Form 4
| +8.77% | 9.76K |
$45.06 | -$196,506.66 | 121.1K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +9.87% | 10K |
$20.17 | $201,713.00 | 111.33K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +364.63% | 79.53K |
$17.00 |
—
| 101.33K |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GENZYME CORP No price found
ExecVP,Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.88K |
$74.00 | -$3,043,398.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +114.00% | 5.35K |
$45.60 | -$124,579.20 | 10.04K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
$37.78 | -$371,969.28 | 4.69K |
Scheduled
|
May 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +89.81% | 2K |
$51.95 | $103,906.40 | 4.23K |
Apr 23
| |||
Form 4
|
—
|
0
|
$51.89 | -$1,113,654.00 | 1.89K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SAVIENT PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.64K |
$1.17 | $14,793.48 | 12.64K |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MyoKardia Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.10K |
—
|
—
|
0
|
Nov 17
| |||
Form 4/A
|
∞
| 2.3K |
—
|
—
| 2.3K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 2.3K |
—
|
—
| 2.3K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.18 | -$6,838.88 | 352.49K |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +36.35% | 352.49K |
$10.00 | $112,500.00 | 1.32M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |